History of Eicosanoids Overview of Eicosanoid Biosynthesis Antagonists of Eicosanoids and Inhibitors of Their Synthesis Lung Pharmacology of Eicosanoids Inactivation of Eicosanoids in Lung Synthesis of Eicosanoids by LungSynthesis from exogenous arachidonic acid Synthesis from endogenous arachidonic acid Release of eicosanoids after anaphylactic reactions Release of eicosanoids by mechanical stimulation Release of eicosanoids by endogenous mediators Summary SINCE THE RENAISSANCE of interest in metabolic functions of the lung in the late 1960s, our knowledge of these functions has grown at an exponential rate common to many fields of research. Within this rapidly growing field, however, one area has expanded in an almost explosive manner: the study of the metabolism of arachidonic acid (AA) and its oxygenated metabolites in the lung. These metabolites [prostaglandins (PGs), prostacyclin, thromboxanes, and leukotrienes] are all, like AA, basically molecules containing 20 carbon atoms. Because the chemical name for AA is eicosatrienoic acid, these metabolites and their precursors are often called eicosanoids.An early paper on PG biosynthesis demonstrated a highly active enzyme in guinea pig lung extracts (16), and the most recent advance in eicosanoid biochemistry was the identification of leukotrienes generated by lung tissue during anaphylaxis (195). These developments increased our knowledge of the lung and are important and sometimes essential elements in the development of our understanding of the eicosanoids in general.
HISTORY OF EICOSANOIDS